Singapore markets close in 3 hours 19 minutes

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.1200-0.2300 (-5.29%)
At close: 4:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts6666
Avg. Estimate-0.48-0.51-2.23-1.36
Low estimate-0.54-0.76-2.49-1.86
High estimate-0.44-0.41-2.06-0.8
Year ago EPS-0.89-1.02-4.38-2.23
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts6666
Avg. Estimate39.09M41.76M155.56M207.57M
Low estimate37.3M38.3M150.5M189M
High estimate40.5M45.76M161.14M231.07M
Year ago salesN/A43.3M164.52M155.56M
Sales growth (year/est)N/A-3.60%-5.40%33.40%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS-0.99-0.77-0.72-0.56
Actual EPS-0.89-1.02-0.64-0.61
Difference0.1-0.250.08-0.05
Surprise %10.10%-32.50%11.10%-8.90%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.48-0.51-2.23-1.36
7 days ago-0.48-0.5-2.2-1.36
30 days ago-0.48-0.5-2.2-1.32
60 days ago-0.49-0.51-2.22-1.34
90 days ago-0.53-0.58-2.29-1.21
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesCLVSIndustrySector(s)S&P 500
Current qtr.46.10%N/AN/AN/A
Next qtr.50.00%N/AN/AN/A
Current year49.10%N/AN/AN/A
Next year39.00%N/AN/AN/A
Next 5 years (per annum)79.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A